Edition:
United States

Acrux Ltd (ACR.AX)

ACR.AX on Australia Stock Exchange

0.16AUD
19 Sep 2017
Change (% chg)

$-0.01 (-5.88%)
Prev Close
$0.17
Open
$0.17
Day's High
$0.17
Day's Low
$0.16
Volume
850,844
Avg. Vol
411,233
52-wk High
$0.38
52-wk Low
$0.16

Chart for

About

Acrux Limited is a drug development company. The Company is engaged in developing and commercializing branded and generic transdermal and topical pharmaceuticals for global markets. The Company's transdermal or topical pharmaceutical product portfolio can be segregated into approximately two streams, such as generic pharmaceutic... (more)

Overall

Beta: 1.19
Market Cap(Mil.): $28.31
Shares Outstanding(Mil.): 166.52
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.87 16.18
EPS (TTM): -- -- --
ROI: -- 15.15 14.60
ROE: -- 16.38 13.87

BRIEF-Acrux says co and Eli Lilly and Co agreed to terminate licensing agreement for Axiron

* Acrux and Eli Lilly and Company have mutually agreed to terminate their licensing agreement for Axiron

Sep 05 2017

BRIEF-Acrux posts FY net loss for period attributable of $243,000

* FY revenue from ordinary activities down 16 percent to $23.9 million

Aug 22 2017

Earnings vs. Estimates